Seeking Alpha

  Novartis AG - NYSE

11/23/2014, 10:09 PM ET
  • Michael Bryant | Send Message 10 Dec 2012

    "Novartis ($NVS) says trial results back Tasigna drug." Another buy and hold and reinvest the dividends.
      NVS vs. ETF Alternatives
      Company Description
      Novartis AG is engaged in the research, development, manufacturing and marketing of healthcare products and pharmaceuticals.